SCHEMBL8934505

SCHEMBL8934505

COc1ccc(-c2cc(=O)c3cc(OC)c(OC)cc3o2)cc1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.69
CYP1B1 Q16678 3/20 0.69
KDM4E B2RXH2 4/20 0.68
ALDH1A1 P00352 3/20 0.68
HSD17B10 Q99714 3/20 0.68
CYP2C19 P33261 3/20 0.68
CYP2D6 P10635 2/20 0.68
TP53 P04637 1/20 0.68
CYP3A4 P08684 3/20 0.67
HPGD P15428 3/20 0.67
CYP2C9 P11712 2/20 0.67
FYN P06241 1/20 0.67
AURKA O14965 1/20 0.66
KDR P35968 1/20 0.66
FLT3 P36888 1/20 0.66
AURKB Q96GD4 1/20 0.66
CSNK2A2 P19784 8/20 0.65
CSNK2B P67870 8/20 0.65
CSNK2A1 P68400 8/20 0.65
KDM1A O60341 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10068612 0.92 CSNK2A2 (0.69) KDM4EALDH1A1HSD17B10CYP2C19CYP2D6
SCHEMBL7603180 0.91 FYN (0.73) CYP1B1KDM4EALDH1A1HSD17B10CYP2C19
SCHEMBL29435863 0.87 CSNK2A2 (0.81) CYP1A1CYP1B1KDM4EALDH1A1HSD17B10
SCHEMBL26117897 0.87 CSNK2A2 (0.81) CYP1A1CYP1B1KDM4EALDH1A1HSD17B10
SCHEMBL30960382 0.87 TNKS (0.71) CYP1A1CYP1B1KDM4EALDH1A1HSD17B10
SCHEMBL1744293 0.87 TNKS (0.71) CYP1A1CYP1B1KDM4EALDH1A1HSD17B10
SCHEMBL8934614 0.86 KDM4E (0.74) CYP1A1CYP1B1KDM4EALDH1A1HSD17B10
SCHEMBL5320080 0.85 KDM4E (0.81) CYP1A1CYP1B1KDM4EALDH1A1HSD17B10
SCHEMBL8934571 0.85 CSNK2A2 (0.82) CYP1A1CYP1B1KDM4ECYP2C19CYP2D6
SCHEMBL6129133 0.83 TUBB4A (0.71) CYP1A1CYP1B1ALDH1A1CYP3A4AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO claimed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed